195 related articles for article (PubMed ID: 11522679)
1. Overexpression of Cu2+/Zn2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice.
Craven PA; Melhem MF; Phillips SL; DeRubertis FR
Diabetes; 2001 Sep; 50(9):2114-25. PubMed ID: 11522679
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of manganese superoxide dismutase suppresses increases in collagen accumulation induced by culture of mesangial cells in high-media glucose.
Craven PA; Phillips SL; Melhem MF; Liachenko J; DeRubertis FR
Metabolism; 2001 Sep; 50(9):1043-8. PubMed ID: 11555836
[TBL] [Abstract][Full Text] [Related]
3. Effects of dietary supplementation of alpha-lipoic acid on early glomerular injury in diabetes mellitus.
Melhem MF; Craven PA; Derubertis FR
J Am Soc Nephrol; 2001 Jan; 12(1):124-133. PubMed ID: 11134258
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction.
DeRubertis FR; Craven PA; Melhem MF; Salah EM
Diabetes; 2004 Mar; 53(3):762-8. PubMed ID: 14988262
[TBL] [Abstract][Full Text] [Related]
5. Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempol.
DeRubertis FR; Craven PA; Melhem MF
Metabolism; 2007 Sep; 56(9):1256-64. PubMed ID: 17697870
[TBL] [Abstract][Full Text] [Related]
6. Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes.
Melhem MF; Craven PA; Liachenko J; DeRubertis FR
J Am Soc Nephrol; 2002 Jan; 13(1):108-116. PubMed ID: 11752027
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice.
Sharma K; Jin Y; Guo J; Ziyadeh FN
Diabetes; 1996 Apr; 45(4):522-30. PubMed ID: 8603776
[TBL] [Abstract][Full Text] [Related]
8. Ras modulation of superoxide activates ERK-dependent fibronectin expression in diabetes-induced renal injuries.
Lin CL; Wang FS; Kuo YR; Huang YT; Huang HC; Sun YC; Kuo YH
Kidney Int; 2006 May; 69(9):1593-600. PubMed ID: 16572112
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R
FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958
[TBL] [Abstract][Full Text] [Related]
10. SOD1, but not SOD3, deficiency accelerates diabetic renal injury in C57BL/6-Ins2(Akita) diabetic mice.
Fujita H; Fujishima H; Takahashi K; Sato T; Shimizu T; Morii T; Shimizu T; Shirasawa T; Qi Z; Breyer MD; Harris RC; Yamada Y; Takahashi T
Metabolism; 2012 Dec; 61(12):1714-24. PubMed ID: 22632894
[TBL] [Abstract][Full Text] [Related]
11. Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
Masuda K; Tanabe K; Ujike H; Hinamoto N; Miyake H; Tanimura S; Sugiyama H; Sato Y; Maeshima Y; Wada J
PLoS One; 2018; 13(4):e0195779. PubMed ID: 29641565
[TBL] [Abstract][Full Text] [Related]
12. Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes.
Craven PA; DeRubertis FR; Kagan VE; Melhem M; Studer RK
J Am Soc Nephrol; 1997 Sep; 8(9):1405-14. PubMed ID: 9294832
[TBL] [Abstract][Full Text] [Related]
13. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
Mizuno S; Nakamura T
Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
15. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats.
Qi MY; Kai-Chen ; Liu HR; Su YH; Yu SQ
J Ethnopharmacol; 2011 Dec; 138(3):731-6. PubMed ID: 22027446
[TBL] [Abstract][Full Text] [Related]
17. Effects of antihypertensive drugs or glycemic control on antioxidant enzyme activities in spontaneously hypertensive rats with diabetes.
Tang Z; Shou I; Wang LN; Fukui M; Tomino Y
Nephron; 1997; 76(3):323-30. PubMed ID: 9226234
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats.
Yuan J; Jia R; Bao Y
J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):118-26. PubMed ID: 17907099
[TBL] [Abstract][Full Text] [Related]
19. F(2)-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes.
Montero A; Munger KA; Khan RZ; Valdivielso JM; Morrow JD; Guasch A; Ziyadeh FN; Badr KF
Kidney Int; 2000 Nov; 58(5):1963-72. PubMed ID: 11044216
[TBL] [Abstract][Full Text] [Related]
20. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.
Ziyadeh FN; Hoffman BB; Han DC; Iglesias-De La Cruz MC; Hong SW; Isono M; Chen S; McGowan TA; Sharma K
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):8015-20. PubMed ID: 10859350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
